Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QDHH | ISIN: CA67079A1021 | Ticker-Symbol: 62E
Tradegate
11.11.24
14:57 Uhr
31,600 Euro
-0,600
-1,86 %
1-Jahres-Chart
NUVEI CORPORATION Chart 1 Jahr
5-Tage-Chart
NUVEI CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
31,40033,20008:45
32,00032,40008:00
PR Newswire
84 Leser
Artikel bewerten:
(0)

Nuvei Announces Third Quarter 2024 Results

Finanznachrichten News

Nuvei reports in U.S. dollars and in accordance with International Financial Reporting Standards ("IFRS")

MONTREAL, Nov. 12, 2024 /PRNewswire/ -- Nuvei Corporation ("Nuvei" or the "Company") (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, today reported its financial results for the three and nine months ended September 30, 2024.

"We are pleased to report third quarter financial results that underscore the rapid scaling of our business, with total volume increasing 27% and revenue higher by 17% year-over-year, setting us up well to achieve our targeted growth in the quarters and years ahead as we deliver more differentiated value across our global payment solutions platform," said Philip Fayer, Nuvei Chair and CEO. "Our business remains highly profitable, with third quarter margins reflecting opportunistic investments to expand our global footprint. As we look to finalize our pending take-private, we are already executing on a highly compelling value creation plan, and we have initiated the process of adding 300-plus new roles across our product, technology, and commercial teams," concluded Fayer.

Financial Highlights for the Three Months Ended September 30, 2024 Compared to 2023:

  • Total volume(a) increased by 27% to $61.3 billion from $48.2 billion;
  • Revenue increased by 17% to $357.6 million from $304.9 million
  • Net income increased to $17.2 million from a net loss of $18.1 million;
  • Adjusted EBITDA(b) decreased by 2% to $108.8 million from $110.7 million;
  • Adjusted net income(b) decreased by 8% to $52.3 million from $56.8 million;
  • Net income per diluted share increased to $0.10 from a net loss per diluted share of $0.14;
  • Adjusted net income per diluted share(b) decreased by 13% to $0.34 from $0.39;
  • Adjusted EBITDA less capital expenditures(b) decreased to $92.6 million from $97.5 million.

Financial Highlights for the Nine Months Ended September 30, 2024 Compared to 2023:

  • Total volume(a) increased by 30% to $183.1 billion from $141.2 billion;
  • Revenue increased 20% to $1,038.2 million from $868.4 million;
  • Net income increased to $17.8 million from a net loss of $14.8 million;
  • Adjusted EBITDA(b) increased by 7% to $340.4 million from $317.3 million;
  • Adjusted net income(b) decreased by 1% to $177.4 million from $179.3 million;
  • Net income per diluted share increased to $0.08 from a net loss per diluted share of $0.14;
  • Adjusted net income per diluted share(b) decreased by 4% to $1.16 from $1.21;
  • Adjusted EBITDA less capital expenditures(b)increased by 4% to $288.0 million from $277.0 million; and,
  • Cash dividends declared were $42.3 million.

(a) Total volume does not represent revenue earned by the Company, but rather the total dollar value of transactions processed by merchants under contractual agreement with the Company. See "Non-IFRS and Other Financial Measures".

(b) Adjusted EBITDA, Adjusted net income, Adjusted net income per diluted share and Adjusted EBITDA less capital expenditures are non-IFRS measures and non-IFRS ratios. These measures are not recognized measures under IFRS and do not have standardized meanings prescribed by IFRS and therefore may not be comparable to similar measures presented by other companies. See "Non-IFRS and Other Financial Measures".

Proposed take private transaction

As previously announced, on April 1, 2024 the Company entered into a definitive arrangement agreement to be taken private by Advent International ("Advent"), one of the world's largest and most experienced global private equity investors, as well as a longstanding sponsor in the payments space, alongside existing Canadian shareholders Philip Fayer, certain investment funds managed by Novacap Management Inc. and Caisse de dépôt et placement du Québec, in an all-cash transaction which values the Company at an enterprise value of approximately $6.3 billion (the "Proposed transaction"). Advent will acquire all the issued and outstanding Subordinate Voting Shares and any Multiple Voting Shares (collectively the "Shares") that are not Rollover Shares1, for a price of $34.00 per Share, in cash. This price represents an attractive and significant premium of approximately 56% to the closing price of the Subordinate Voting Shares on the Nasdaq Global Select Market ("Nasdaq") on March 15, 2024, the last trading day prior to media reports concerning a potential transaction involving the Company, and a premium of approximately 48% to the 90-day volume weighted average trading price per Subordinate Voting Share as of such date.

The Proposed transaction will be implemented by way of a statutory plan of arrangement under the Canada Business Corporations Act. The Proposed transaction was approved by shareholders at a special meeting held on June 18, 2024 and received court approval on June 20, 2024. The Proposed transaction remains subject to customary closing conditions, including receipt of key regulatory approvals (a majority of which were received and/or for which the waiting period has expired as of the date hereof, with a limited number of approvals remaining outstanding), is not subject to any financing condition and, assuming the timely receipt of all required key regulatory approvals, is expected to close in the fourth quarter of 2024.

Following completion of the transaction, it is expected that the Subordinate Voting Shares will be delisted from each of the Toronto Stock Exchange and the Nasdaq and that Nuvei will cease to be a reporting issuer in all applicable Canadian jurisdictions and will deregister the Subordinate Voting Shares with the U.S. Securities and Exchange Commission (the "SEC").

1 Philip Fayer, Novacap and CDPQ (together with entities they control directly or indirectly, collectively, the "Rollover Shareholders") have agreed to roll approximately 95%, 65% and 75%, respectively, of their Shares (the "Rollover Shares") and are expected to receive in aggregate approximately US$560 million in cash for the Shares sold on closing. Philip Fayer, Novacap and CDPQ are expected to indirectly own or control approximately 24%, 18% and 12%, respectively, of the equity in the resulting private company. Percentages and amount of expected cash proceeds are based on current assumed cash position and are subject to change as a result of cash generated before closing.

Cash Dividend

Nuvei today announced that its Board of Directors has authorized and declared a cash dividend of $0.10 per Subordinate Voting Share and Multiple Voting Share, payable on December 12, 2024 to shareholders of record on November 26, 2024. The aggregate amount of the dividend is expected to be approximately $14 million, to be funded from the Company's existing cash on hand. In accordance with the Plan of arrangement, shareholders are entitled to dividends with a record date prior to the effective date of the Proposed transaction. Should the Proposed transaction be completed before the record date, the dividend will not be paid. Accordingly, payment of the dividend will be made on December 12, 2024 if the Proposed transaction is not completed prior to the record date of November 26, 2024.

The Company, for the purposes of the Income Tax Act (Canada) and any similar provincial or territorial legislation, designates the dividend declared for the quarter ended September 30, 2024, and any future dividends, to be eligible dividends. The Company further expects to report such dividends as a dividend to U.S. shareholders for U.S. federal income tax purposes. Subject to applicable limitations, dividends paid to certain non-corporate U.S. shareholders may be eligible for taxation as "qualified dividend income" and therefore may be taxable at rates applicable to long-term capital gains. A U.S. shareholder should talk to its advisor regarding such dividends, including with respect to the "extraordinary dividend" provisions of the Internal Revenue Code (US).

The declaration, timing, amount and payment of future dividends remain at the discretion of the Board of Directors, as more fully described under the heading "Forward-Looking Information" of this press release.

Conference Call, Financial Outlook and Growth Targets

In light of the Proposed transaction, Nuvei no longer holds earnings conference calls or provides a financial outlook or growth targets.

About Nuvei

Nuvei (Nasdaq: NVEI) (TSX: NVEI) is the Canadian fintech company accelerating the business of clients around the world. Nuvei's modular, flexible and scalable technology allows leading companies to accept next-gen payments, offer all payout options and benefit from card issuing, banking, risk and fraud management services. Connecting businesses to their customers in more than 200 markets, with local acquiring in 50 markets, 150 currencies and 720 alternative payment methods, Nuvei provides the technology and insights for customers and partners to succeed locally and globally with one integration.

For more information, visit www.nuvei.com

Non-IFRS and Other Financial Measures

Nuvei's condensed interim consolidated financial statements have been prepared in accordance with IFRS applicable to the preparation of interim financial statements, including IAS 34, Interim Financial Reporting, as issued by the IASB. The information presented in this press release includes non-IFRS financial measures, non-IFRS financial ratios and supplementary financial measures, namely Adjusted EBITDA, Adjusted net income, Adjusted net income per basic share, Adjusted net income per diluted share, Adjusted EBITDA less capital expenditures and Total volume. These measures are not recognized measures under IFRS and do not have standardized meanings prescribed by IFRS and therefore may not be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS measures by providing further understanding of our results of operations from our perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of the Company's financial statements reported under IFRS. These measures are used to provide investors with additional insight of our operating performance and thus highlight trends in Nuvei's business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use these non-IFRS and other financial measures in the evaluation of issuers. We also use these measures to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. We believe these measures are important additional measures of our performance, primarily because they and similar measures are used widely among others in the payment technology industry as a means of evaluating a company's underlying operating performance.

Non-IFRS Financial Measures

Adjusted EBITDA: We use Adjusted EBITDA as a means to evaluate operating performance, by eliminating the impact of non-operational or non-cash items. Adjusted EBITDA is defined as net income (loss) before finance costs (recovery), finance income, depreciation and amortization, income tax expense, acquisition, integration and severance costs, share-based payments and related payroll taxes, loss (gain) on foreign currency exchange, and legal settlement and other.

Adjusted EBITDA less capital expenditures: We use Adjusted EBITDA less capital expenditures (which we define as acquisition of intangible assets and property and equipment) as a supplementary indicator of our operating performance.

Adjusted net income: We use Adjusted net income as an indicator of business performance and profitability with our current tax and capital structure. Adjusted net income is defined as net income (loss) before acquisition, integration and severance costs, share-based payments and related payroll taxes, loss (gain) on foreign currency exchange, amortization of acquisition-related intangible assets, and the related income tax expense or recovery for these items. Adjusted net income also excludes change in redemption value of liability-classified common and preferred shares, change in fair value of share repurchase liability and accelerated amortization of deferred financing fees and legal settlement and other.

Non-IFRS Financial Ratios

Adjusted net income per basic share and per diluted share: We use Adjusted net income per basic share and per diluted share as an indicator of performance and profitability of our business on a per share basis. Adjusted net income per basic share and per diluted share means Adjusted net income less net income attributable to non-controlling interest divided by the basic and diluted weighted average number of common shares outstanding for the period, respectively. The number of share-based awards used in the diluted weighted average number of common shares outstanding in the Adjusted net income per diluted share calculation is determined using the treasury stock method as permitted under IFRS.

Supplementary Financial Measures

We monitor the following key performance indicators to help us evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. Our key performance indicators may be calculated in a manner that differs from similar key performance indicators used by other companies.

Total volume: We believe Total volume is an indicator of performance of our business. Total volume and similar measures are used widely among others in the payments industry as a means of evaluating a company's performance. We define Total volume as the total dollar value of transactions processed in the period by customers under contractual agreement with us. Total volume does not represent revenue earned by us. Total volume includes acquiring volume, where we are in the flow of funds in the settlement transaction cycle, gateway/technology volume, where we provide our gateway/technology services but are not in the flow of funds in the settlement transaction cycle, as well as the total dollar value of transactions processed relating to APMs and payouts. Since our revenue is primarily sales volume and transaction-based, generated from merchants' daily sales and through various fees for value-added services provided to our customers, fluctuations in Total volume will generally impact our revenue.

Forward-Looking Information

This press release contains "forward-looking information" and "forward-looking statements" (collectively, "Forward-looking information") within the meaning of applicable securities laws. Such forward-looking information may include, without limitation, information with respect to our objectives and the strategies to achieve these objectives, as well as information with respect to our beliefs, plans, expectations, anticipations, estimates and intentions. This forward-looking information is identified by the use of terms and phrases such as "may", "would", "should", "could", "expect", "intend", "estimate", "anticipate", "plan", "foresee", "believe", or "continue", the negative of these terms and similar terminology, including references to assumptions, although not all forward-looking information contains these terms and phrases. Particularly, information regarding our expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate, expectations regarding industry trends and the size and growth rates of addressable markets, our business plans and growth strategies, addressable market opportunity for our solutions, expectations regarding growth and cross-selling opportunities and intention to capture an increasing share of addressable markets, the costs and success of our sales and marketing efforts, intentions to expand existing relationships, further penetrate verticals, enter new geographical markets, expand into and further increase penetration of international markets, intentions to selectively pursue and successfully integrate acquisitions, and expected acquisition outcomes, cost savings, synergies and benefits, including with respect to the acquisition of Paya, future investments in our business and anticipated capital expenditures, our intention to continuously innovate, differentiate and enhance our platform and solutions, expected pace of ongoing legislation of regulated activities and industries, our competitive strengths and competitive position in our industry, and expectations regarding our revenue, revenue mix and the revenue generation potential of our solutions and expectations regarding our margins and future profitability, as well as statements regarding the Proposed transaction with Advent International L.P., alongside existing Canadian shareholders Philip Fayer, certain investment funds managed by Novacap Management Inc., and Caisse de dépôt et placement du Québec, including the proposed timing and various steps contemplated in respect of the transaction and statements regarding the plans, objectives, and intentions of Philip Fayer, certain investment funds managed by Novacap Management Inc., Caisse de dépôt et placement du Québec or Advent, are forward-looking information. Economic and geopolitical uncertainties, including regional conflicts and wars, including potential impacts of sanctions, may also heighten the impact of certain factors described herein.

In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances.

Forward-looking information is based on management's beliefs and assumptions and on information currently available to management, regarding, among other things, assumptions regarding foreign exchange rate, competition, political environment and economic performance of each region where the Company operates and general economic conditions and the competitive environment within our industry, including the following assumptions: (a) the Company will continue to effectively execute against its key strategic growth priorities, without any material adverse impact from macroeconomic or geopolitical headwinds on its or its customers' business, financial condition, financial performance, liquidity or any significant reduction in demand for its products and services, (b) the economic conditions in our core markets, geographies and verticals, including resulting consumer spending and employment, remaining at close to current levels, (c) assumptions as to foreign exchange rates and interest rates, including inflation, (d) the Company's continued ability to manage its growth effectively, (e) the Company's ability to continue to attract and retain key talent and personnel required to achieve its plans and strategies, including sales, marketing, support and product and technology operations, in each case both domestically and internationally, (f) the Company's ability to successfully identify, complete, integrate and realize the expected benefits of past and recent acquisitions and manage the associated risks, as well as future acquisitions, (g) the absence of adverse changes in legislative or regulatory matters, (h) the Company's continued ability to upskill and modify its compliance capabilities as regulations change or as the Company enters new markets or offers new products or services, (i) the Company's continued ability to access liquidity and capital resources, including its ability to secure debt or equity financing on satisfactory terms, and (j) the absence of adverse changes in current tax laws. Unless otherwise indicated, forward-looking information does not give effect to the potential impact of any mergers, acquisitions, divestitures or business combinations that may be announced or closed after the date hereof. Although the forward-looking information contained herein is based upon what we believe are reasonable assumptions, investors are cautioned against placing undue reliance on this information since actual results may vary from the forward-looking information.

Forward-looking information involves known and unknown risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. These risks and uncertainties include, but are not limited to, the risk factors described in greater detail under "Risk Factors" of the Company's annual information form ("AIF") and the "Risk Factor's" in the Company's management's discussion and analysis of financial condition and results of operations for the three and nine months ended September 30, 2024 ("MD&A"), such as: risks relating to our business, industry and overall economic uncertainty; the rapid developments and change in our industry; substantial competition both within our industry and from other payments providers; challenges implementing our growth strategy; challenges to expand our product portfolio and market reach; changes in foreign currency exchange rates, interest rates, consumer spending and other macroeconomic factors affecting our customers and our results of operations; challenges in expanding into new geographic regions internationally and continuing our growth within our markets; challenges in retaining existing customers, increasing sales to existing customers and attracting new customers; reliance on third-party partners to distribute some of our products and services; risks associated with future acquisitions, partnerships or joint-ventures; challenges related to economic and political conditions, business cycles and credit risks of our customers, such as wars like the Russia - Ukraine and Middle East conflicts and related economic sanctions; the occurrence of a natural disaster, a widespread health epidemic or pandemic or other similar events; history of net losses and additional significant investments in our business; our level of indebtedness; challenges to secure financing on favorable terms or at all; difficulty to maintain the same rate of revenue growth as our business matures and to evaluate our future prospects; inflation; challenges related to a significant number of our customers being small and medium businesses ("SMBs"); a certain degree of concentration in our customer base and customer sectors; compliance with the requirements of payment networks; reliance on, and compliance with, the requirements of acquiring banks and payment networks; challenges related to the reimbursement of chargebacks from our customers; financial liability related to the inability of our customers (merchants) to fulfill their requirements; our bank accounts being located in multiple territories and relying on banking partners to maintain those accounts; decline in the use of electronic payment methods; loss of key personnel or difficulties hiring qualified personnel; deterioration in relationships with our employees; impairment of a significant portion of intangible assets and goodwill; increasing fees from payment networks; misappropriation of end-user transaction funds by our employees; frauds by customers, their customers or others; coverage of our insurance policies; the degree of effectiveness of our risk management policies and procedures in mitigating our risk exposure; the integration of a variety of operating systems, software, hardware, web browsers and networks in our services; the costs and effects of pending and future litigation; various claims such as wrongful hiring of an employee from a competitor, wrongful use of confidential information of third parties by our employees, consultants or independent contractors or wrongful use of trade secrets by our employees of their former employers; deterioration in the quality of the products and services offered; managing our growth effectively; challenges from seasonal fluctuations on our operating results; changes in accounting standards; estimates and assumptions in the application of accounting policies; risks associated with less than full control rights of some of our subsidiaries and investments; challenges related to our holding company structure; impacts of climate change; development of AI and its integration in our operations, as well as risks relating to intellectual property and technology, risks related to data security incidents, including cyber-attacks, computer viruses, or otherwise which may result in a disruption of services or liability exposure; challenges regarding regulatory compliance in the jurisdictions in which we operate, due to complex, conflicting and evolving local laws and regulations and legal proceedings and risks relating to our Subordinate Voting Shares. These risks and uncertainties further include (but are not limited to) as concerns the Proposed transaction with Advent, the failure of the parties to obtain the necessary regulatory approvals or to otherwise satisfy the conditions to the completion of the transaction, failure of the parties to obtain such approvals or satisfy such conditions in a timely manner, significant transaction costs or unknown liabilities, failure to realize the expected benefits of the transaction, and general economic conditions. Failure to obtain the necessary regulatory approvals, or the failure of the parties to otherwise satisfy the conditions to the completion of the transaction or to complete the transaction, may result in the transaction not being completed on the proposed terms, or at all. In addition, if the transaction is not completed, and the Company continues as a publicly-traded entity, there are risks that the announcement of the Proposed transaction and the dedication of substantial resources of the Company to the completion of the transaction could have an impact on its business and strategic relationships (including with future and prospective employees, customers, suppliers and partners), operating results and activities in general, and could have a material adverse effect on its current and future operations, financial condition and prospects. Furthermore, in certain circumstances, the Company may be required to pay a termination fee pursuant to the terms of the arrangement agreement which could have a material adverse effect on its financial position and results of operations and its ability to fund growth prospects and current operations.

Our dividend policy is at the discretion of the Board. Any future determination to declare cash dividends on our securities will be made at the discretion of our Board, subject to applicable Canadian laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions (including covenants contained in our credit facilities), general business conditions and other factors that our Board may deem relevant. Further, our ability to pay dividends, as well as make share repurchases, will be subject to applicable laws and contractual restrictions contained in the instruments governing our indebtedness, including our credit facility. Any of the foregoing may have the result of restricting future dividends or share repurchases.

Consequently, all of the forward-looking information contained herein is qualified by the foregoing cautionary statements, and there can be no guarantee that the results or developments that we anticipate will be realized or, even if substantially realized, that they will have the expected consequences or effects on our business, financial condition or results of operation. Unless otherwise noted or the context otherwise indicates, the forward-looking information contained herein represents our expectations as of the date hereof or as of the date it is otherwise stated to be made, as applicable, and is subject to change after such date. However, we disclaim any intention or obligation or undertaking to update or amend such forward-looking information whether as a result of new information, future events or otherwise, except as may be required by applicable law.

Contact:
Investors

Chris Mammone, Head of Investor Relations
[email protected]

Statements of Profit or Loss and Comprehensive Income or Loss Data

(in thousands of US dollars except for shares and per share amounts)



Three months ended

September 30

Nine months ended

September 30


2024

2023

2024

2023


$

$

$

$

Revenue

357,618

304,852

1,038,205

868,376

Cost of revenue

72,051

55,650

204,820

164,172

Gross profit

285,567

249,202

833,385

704,204

Selling, general and administrative expenses

239,108

217,282

697,701

633,655

Operating profit

46,459

31,920

135,684

70,549

Finance income

(1,163)

(2,713)

(2,551)

(9,049)

Finance cost

29,045

30,053

88,648

77,839

Net finance cost

27,882

27,340

86,097

68,790

Loss (gain) on foreign currency exchange

(6,572)

13,033

10,933

520

Income (loss) before income tax

25,149

(8,453)

38,654

1,239

Income tax expense

7,914

9,667

20,878

16,031

Net income (loss)

17,235

(18,120)

17,776

(14,792)






Other comprehensive income (loss), net of tax





Foreign operations - foreign currency translation
differences

8,483

1,257

11,097

(2,753)

Change in fair value of financial instruments
designated as cash flow hedges

(7,187)

(1,008)

(628)

(1,008)

Reclassification of change in fair value of
financial instruments designated as cash flow
hedges to profit and loss

(742)

-

(1,747)

-

Comprehensive income (loss)

17,789

(17,871)

26,498

(18,553)

Net income (loss) attributable to:





Common shareholders of the Company

15,364

(19,814)

11,966

(19,669)

Non-controlling interest

1,871

1,694

5,810

4,877


17,235

(18,120)

17,776

(14,792)

Comprehensive income (loss) attributable to:





Common shareholders of the Company

15,918

(19,565)

20,688

(23,430)

Non-controlling interest

1,871

1,694

5,810

4,877


17,789

(17,871)

26,498

(18,553)

Weighted average number of common shares
outstanding





Basic

141,954,687

139,138,382

140,736,389

139,209,728

Diluted

148,450,964

139,138,382

147,468,942

139,209,728






Net income (loss) per share attributable to
common shareholders of the Company





Basic

0.11

(0.14)

0.09

(0.14)

Diluted

0.10

(0.14)

0.08

(0.14)

Consolidated Statements of Financial Position Data

(in thousands of US dollars)


September 30, 2024

December 31, 2023


$

$

Assets






Current assets



Cash and cash equivalents

138,027

170,435

Trade and other receivables

134,397

105,755

Inventory

3,194

3,156

Prepaid expenses

20,999

16,250

Income taxes receivable

994

4,714

Current portion of contract assets

1,738

1,038

Other current assets

692

7,582




Total current assets before segregated funds

300,041

308,930

Segregated funds

1,513,544

1,455,376

Total current assets

1,813,585

1,764,306




Non-current assets



Property and equipment

39,033

33,094

Intangible assets

1,331,859

1,305,048

Goodwill

1,989,858

1,987,737

Deferred tax assets

5,125

4,336

Contract assets

866

835

Processor and other deposits

5,411

4,310

Other non-current assets

36,820

35,601

Total Assets

5,222,557

5,135,267

Liabilities






Current liabilities



Trade and other payables

196,793

179,415

Income taxes payable

20,684

25,563

Current portion of loans and borrowings

6,833

12,470

Other current liabilities

11,780

7,859




Total current liabilities before due to merchants

236,090

225,307

Due to merchants

1,513,544

1,455,376




Total current liabilities

1,749,634

1,680,683




Non-current liabilities



Loans and borrowings

1,241,175

1,248,074

Deferred tax liabilities

126,581

151,921

Other non-current liabilities

9,477

10,374




Total Liabilities

3,126,867

3,091,052







Equity






Equity attributable to shareholders



Share capital

2,016,003

1,969,734

Contributed surplus

362,249

324,941

Deficit

(255,226)

(224,902)

Accumulated other comprehensive loss

(34,734)

(43,456)





2,088,292

2,026,317

Non-controlling interest

7,398

17,898




Total Equity

2,095,690

2,044,215




Total Liabilities and Equity

5,222,557

5,135,267

Consolidated Statements of Cash Flow Data

(in thousands of U.S. dollars)



For the nine months ended September 30

2024

2023


$

$

Cash flow from operating activities



Net income (loss)

17,776

(14,792)

Adjustments for:



Depreciation of property and equipment

13,244

10,739

Amortization of intangible assets

100,696

89,386

Amortization of contract assets

1,159

1,176

Share-based payments

65,297

105,484

Net finance cost

86,097

68,790

Loss on foreign currency exchange

10,933

520

Income tax expense

20,878

16,031

Gain on business combination

(4,013)

-

Loss on disposal

551

-

Changes in non-cash working capital items:

(31,509)

(3,473)

Interest paid

(85,216)

(69,298)

Interest received

18,838

9,921

Income taxes paid - net of tax received

(43,463)

(32,208)


171,268

182,276

Cash flow used in investing activities



Business acquisitions, net of cash acquired

(1,185)

(1,379,778)

Acquisition of property and equipment

(12,020)

(7,879)

Acquisition of intangible assets

(40,355)

(32,371)

Acquisition of distributor commissions

(56,704)

(20,318)

Disposal (acquisition) of other non-current assets

468

(31,223)

Net decrease in processor deposits

3,472

-

Net decrease in advances to third parties

-

245


(106,324)

(1,471,324)

Cash flow from (used in) financing activities



Shares repurchased and cancelled

-

(56,042)

Proceeds from exercise of stock options

16,029

7,728

Repayment of loans and borrowings

(49,154)

(112,840)

Proceeds from loans and borrowings

-

852,000

Financing fees related to loans and borrowings

(249)

(14,650)

Payment of lease liabilities

(5,138)

(3,965)

Dividends paid to shareholders

(42,275)

(13,907)

Dividend paid by subsidiary to non-controlling interest

(16,310)

-


(97,097)

658,324

Effect of movements in exchange rates on cash

(255)

37

Net decrease in cash and cash equivalents

(32,408)

(630,687)

Cash and cash equivalents - Beginning of period

170,435

751,686

Cash and cash equivalents - End of period

138,027

120,999

Reconciliation of Adjusted EBITDA and Adjusted EBITDA less capital expenditures to Net Income

(In thousands of US dollars)



Three months ended
September 30

Nine months ended
September 30


2024

2023

2024

2023


$

$

$

$






Net income (loss)

17,235

(18,120)

17,776

(14,792)

Finance cost

29,045

30,053

88,648

77,839

Finance income

(1,163)

(2,713)

(2,551)

(9,049)

Depreciation and amortization

39,105

36,544

113,940

100,125

Income tax expense

7,914

9,667

20,878

16,031

Acquisition, integration and severance costs(a)

7,675

5,120

24,295

37,000

Share-based payments and related payroll taxes (b)

15,416

34,102

70,158

106,423

Loss (gain) on foreign currency exchange

(6,572)

13,033

10,933

520

Legal settlement and other(c)

131

3,014

(3,663)

3,192

Adjusted EBITDA

108,786

110,700

340,414

317,289

Acquisition of property and equipment, and intangible assets

(16,233)

(13,205)

(52,375)

(40,250)

Adjusted EBITDA less capital expenditures

92,553

97,495

288,039

277,039




(a)

These expenses relate to:


(i)

professional, legal, consulting, accounting and other fees and expenses related to our acquisition and financing activities, including the expenses related to the Proposed transaction. For the three months and nine months ended September 30, 2024, these expenses were $2.4 million and $16.8 million ($3.4 million and $23.0 million for the three months and nine months ended September 30, 2023). These costs are presented in the professional fees line item of selling, general and administrative expenses.


(ii)

acquisition-related compensation was $0.7 million and $2.4 million for the three months and nine months ended September 30, 2024 and $0.6 million and $3.5 million for the three months and nine months ended September 30, 2023. These costs are presented in the employee compensation line item of selling, general and administrative expenses.


(iii)

change in deferred purchase consideration for previously acquired businesses. No amount was recognized for the three months and nine months ended September 30, 2024 and 2023. These amounts are presented in the contingent consideration adjustment line item of selling, general and administrative expenses.


(iv)

severance and integration expenses, which were $4.6 million and $5.1 million for the three months and nine months ended September 30, 2024 ($1.1 million and $10.6 million for three months and nine months ended September 30, 2023). These expenses are presented in selling, general and administrative expenses and cost of revenue.

(b)

These expenses are recognized in connection with stock options and other awards issued under share-based plans as well as related payroll taxes that are directly attributable to share-based payments. For the three months and nine months ended September 30, 2024, the expenses consisted of non-cash share-based payments of $14.9 million and $65.3 million ($34.0 million and $105.5 million for the three months and nine months ended September 30, 2023), $0.5 million and $4.9 million for related payroll taxes ($0.1 million and $0.9 million for the three months and nine months ended September 30, 2023),

(c)

This primarily represents legal settlements and associated legal costs, as well as non-cash gains, losses and provisions and certain other costs. These costs are presented in selling, general and administrative expenses. For the nine months ended September 30, 2024, the gain consisted mainly of a gain on business combination of $4.0 million.

Reconciliation of Adjusted net income and Adjusted net income per basic share and per diluted share
to Net income (loss)

(In thousands of US dollars except for share and per share amounts)



Three months ended

September 30

Nine months ended

September 30


2024

2023

2024

2023

$

$

$

$






Net income (loss)

17,235

(18,120)

17,776

(14,792)

Change in fair value of share repurchase liability

-

-

-

571

Accelerated amortization of deferred financing fees

-

-

174

-

Amortization of acquisition-related intangible
assets(a)

27,338

27,356

80,821

74,896

Acquisition, integration and severance costs(b)

7,675

5,120

24,295

37,000

Share-based payments and related payroll taxes(c)

15,416

34,102

70,158

106,423

Loss (gain) on foreign currency exchange

(6,572)

13,033

10,933

520

Legal settlement and other(d)

131

3,014

(3,663)

3,192

Adjustments

43,988

82,625

182,718

222,602

Income tax expense related to adjustments(e)

(8,912)

(7,744)

(23,120)

(28,503)

Adjusted net income

52,311

56,761

177,374

179,307

Net income attributable to non-controlling interest

1,871

1,694

5,810

4,877

Adjusted net income attributable to the
common shareholders of the Company

50,440

55,067

171,564

174,430






Weighted average number of common shares
outstanding

141,954,687

139,138,382

140,736,389

139,209,728

Basic

148,450,964

142,386,834

147,468,942

143,632,801

Diluted





Adjusted net income per share attributable
to common shareholders
of the Company (f)





Basic

0.36

0.40

1.22

1.25

Diluted

0.34

0.39

1.16

1.21




(a)

This line item relates to amortization expense taken on intangible assets created from the purchase price adjustment process on acquired companies and businesses and resulting from a change in control of the Company.

(b)

These expenses relate to:


(i)

professional, legal, consulting, accounting and other fees and expenses related to our acquisition and financing activities, including the expenses related to the Proposed transaction. For the three months and nine months ended September 30, 2024, these expenses were $2.4 million and $16.8 million ($3.4 million and $23.0 million for the three months and nine months ended September 30, 2023). These costs are presented in the professional fees line item of selling, general and administrative expenses.


(ii)

acquisition-related compensation was $0.7 million and $2.4 million for the three months and nine months ended September 30, 2024 and $0.6 million and $3.5 million for the three months and nine months ended September 30, 2023. These costs are presented in the employee compensation line item of selling, general and administrative expenses.


(iii)

change in deferred purchase consideration for previously acquired businesses. No amount was recognized for the three months and nine months ended September 30, 2024 and 2023. These amounts are presented in the contingent consideration adjustment line item of selling, general and administrative expenses.


(iv)

severance and integration expenses, which were $4.6 million and $5.1 million for the three months and nine months ended September 30, 2024 ($1.1 million and $10.6 million for the three months and nine months ended September 30, 2023). These expenses are presented in selling, general and administrative expenses and cost of revenue.

(c)

These expenses are recognized in connection with stock options and other awards issued under share-based plans as well as related payroll taxes that are directly attributable to share-based payments. For the three months and nine months ended September 30, 2024, the expenses consisted of non-cash share-based payments of $14.9 million and $65.3 million ($34.0 million and $105.5 million for the three months and nine months ended September 30, 2023), $0.5 million and $4.9 million for related payroll taxes ($0.1 million and $0.9 million for the three months and nine months ended September 30, 2023).

(d)

This primarily represents legal settlements and associated legal costs, as well as non-cash gains, losses and provisions and certain other costs. These costs are presented in selling, general and administrative expenses. For the nine months ended September 30, 2024, the gain consisted mainly of a gain on business combination of $4.0 million.

(e)

This line item reflects income tax expense on taxable adjustments using the tax rate of the applicable jurisdiction.

(f)

The number of share-based awards used in the diluted weighted average number of common shares outstanding in the Adjusted net income per diluted share calculation is determined using the treasury stock method as permitted under IFRS.

Disaggregation of revenue and interest revenue

(In thousands of US dollars)



Three months ended

September 30

Nine months ended

September 30


2024

2023

2024

2023


$

$

$

$






Merchant transaction and processing services revenue

347,224

302,616

1,012,461

862,064

Other revenue

3,722

2,236

9,459

6,312

Interest revenue

6,672

-

16,285

-


357,618

304,852

1,038,205

868,376

SOURCE Nuvei

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.